Home
Martek Announces Settlement...

Martek Announces Settlement of Patent Dispute with Capsugel France

11 Sep 2009
Add foodingredientsfirst as a preferred source on Google
Image

Additionally, Martek and Capsugel will develop a product containing Martek's algal DHA in Capsugel's proprietary Licaps liquid-filled hard capsules.

11 Sep 2009 --- DHA omega-3 innovator and maker of the life'sDHA brand, Martek Biosciences Corporation, announced it has resolved a patent dispute with Capsugel France. The resolution follows Martek's November 2008 action for infringement filed in the High Court of Strasbourg, France.

As a result of this settlement agreement between Martek and Capsugel France, Capsugel and all of its affiliates have agreed to purchase all of their algal DHA exclusively from Martek for the life of the patent in question. Additionally, Martek and Capsugel will develop a product containing Martek's algal DHA in Capsugel's proprietary Licaps liquid-filled hard capsules.

This settlement agreement between Martek and Capsugel does not include Martek's action against Lonza Ltd AG, which continues.

 

All content and features on this website are copyrighted with all rights reserved. The full details can be found in our privacy statement
Add foodingredientsfirst as a preferred source on Google
Save in your AIChatGPTGoogle AIClaudePerplexityGrok
Subscribe to our newsletters
PlatformsFood Ingredients FirstNutrition InsightPackaging InsightsPersonal Care InsightsThe World of Food Ingredients
About usContact usAdvertisingPrivacy statementSitemapArchiveEditorial Team
Follow us
Image